Peptide Pen – Cartalax (Bioregulator Peptide)

Peptide Pen Cartalax is a bioregulatory peptide formulation designed to support joint health, cartilage repair, and overall musculoskeletal function. Cartalax is a short-chain peptide composed of alanine, glutamic acid, and aspartic acid (AED), developed to mimic natural peptides found in cartilage tissue. It is associated with collagen synthesis, cartilage regeneration, extracellular matrix stability, and chondrocyte activity. Key Features: - Bioregulator peptide sequence AED - Supports cartilage repair and joint health - Promotes collagen production and tissue regeneration - Associated with improved mobility and flexibility - Helps support inflammation balance in joints - Pre-filled pen for convenient and consistent dosing Suggested Use: Typically administered in controlled doses as part of a structured protocol. Frequency and dosing may vary depending on individual goals and should be guided by a qualified healthcare provider. Storage: Refrigerate at 2–8°C. Protect from light. Do not freeze. Important Information: Cartalax is considered a research peptide with limited large-scale human clinical data available. This product is intended for use under medical supervision only. Not recommended for persons under 18, pregnant or breastfeeding individuals, or those with certain medical conditions. Always consult a qualified healthcare provider before use.